N
Nazim Uddin
Researcher at China Pharmaceutical University
Publications - 4
Citations - 21
Nazim Uddin is an academic researcher from China Pharmaceutical University. The author has contributed to research in topics: Cancer & Transcriptome. The author has an hindex of 2, co-authored 4 publications receiving 5 citations. Previous affiliations of Nazim Uddin include Bangladesh Council of Scientific and Industrial Research.
Papers
More filters
Journal ArticleDOI
Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles.
TL;DR: The aberrant expression level of SARS-CoV-2-cell receptor gene ACE2 was reported in lung adenocarcinoma (LUAD) comorbidity of COVID-19 patients as mentioned in this paper.
Journal ArticleDOI
Identification of Potential Key Genes and Regulatory Markers in Essential Thrombocythemia Through Integrated Bioinformatics Analysis and Clinical Validation
TL;DR: In this paper, a protein-protein interaction (PPI) network was constructed to identify the differentially expressed genes (DEGs) through comprehensive bioinformatic analysis, and the candidate drugs targeting hub genes were identified using DGIdb database.
Journal ArticleDOI
Contribution of endothelial cell-derived transcriptomes to the colon cancer based on bioinformatics analysis.
TL;DR: The findings revealed that prognosis-associated upregulated hub genes are positively correlated with immune checkpoint markers, including PD-L1 andPD-L2 and the immunosuppressive markers including TGFB1 and TGFBR1.
Journal ArticleDOI
Meta-analysis identifying epithelial-derived transcriptomes predicts poor clinical outcome and immune infiltrations in ovarian cancer.
TL;DR: In this paper, the authors identified 1339 differentially expressed genes (DEGs) in ovarian cancer epithelia including 541 upregulated and 798 downregulated genes.